Mutual tolerance after liver and not after heart transplantation? Evaluation of patient-anti donor and donor-anti-patient responses by mixed lymphocyte culture

Transplant Immunology

Volumn 6, Issue 1, 1998, Pages 33-38

  Van Der Mast, Barbara J ^a,b   Van Besouw, Nicole M ^b   Hepkema, Bouke G ^c   Weimar, Willem ^b   Van De Berg, Aad P ^c   Slooff, Maarten J H ^c   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MIXED LYMPHOCYTE CULTURE; ORGAN DONOR; PRIMED LYMPHOCYTE TYPING; PRIORITY JOURNAL;

EID: 0032029491     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(98)80032-4     Document Type: Article

References (43)

1. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med. 321:1989;701-705.
2. Van der Mast BJ, Balk AH. Effect of HLA-DR-share blood transfusion on the clinical outcome of heart transplantation. Transplantation. 63:1997;1514-1519.
3. Morris RE. Mechanisms of action of new immunosuppressive drugs. Kidney Int. 49:1996;26-38.
4. Strober S, Dhillon M, Schubert M, et al. Acquired immune tolerance to cadaveric renal allografts. N Engl J Med. 321:1989;28-33.
5. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. [Review] Hepatology. 17:1993;1127-1152.
6. Mazariegos GV, Ramos H, Shapiro R, Zeevi A, Fung JJ, Starzl TE. Weaning of immunosuppression in long-term recipients of living-related renal transplants: a preliminary study. Transplant Proc. 27:1995;207-209.
7. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal energy) in a tolerant renal transplant recipient. Transplantation. 59:1995;1147-1155.
8. Charpentier BM, Lang P, Martin B, Fries D. Specific recipient-donor unresponsiveness mediated by a suppressor cell system in human kidney allograft tolerance. Transplantation. 33:1982;470-477.
9. Geppert TD, Davies LS, Gur H, Wacholtz MC, Lipsky PE. Accessory cell signals involved in T-cell activation. Immunol Rev. 117:1990;5-66.
10. Dallman MJ. Cytokines as mediators of organ graft rejection and tolerance. [Review] Curr Opin Immunol. 5:1993;788-793.
11. Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 169:1989;493-502.
12. De Waal LP, van Twuyver E. Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation? [Review] Crit Rev Immunol. 10:1991;417-425.
13. Kahn D, Du Toit E, Jacobson JE, Creemers P. Induction of donor-specific tolerance or sensitization as measured by sequential MLC reactivity up to 24 months after renal transplantation. Transplant Int. 7:1994;S287-S289.
14. Reinsmoen N, Jackson A, McSheery C, et al. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. Transplantation. 60:1995;1546-1554.
15. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation. 55:1993;1272-1277.
16. Mathew JM, Marsh JW, Susskind B, Mohanakumar T. Analysis of T cell responses in liver allograft recipients. J Clin Invest. 91:1993;900-906.
17. Hu H, Robertus M, de Jonge N, et al. Reduction of donor-specific cytotoxic T lymphocyte precursors in peripheral blood of allografted heart recipients. Transplantation. 58:1994;1263-1268.
18. Goulmy E, Blokland E, Persijn GG, Paul LC, Wilmink JM, van Rood JJ. HLA regulates postrenal transplant CML nonreactivity. J Immunol. 135:1985;3082-3086.
19. Burlingham WJ, Grailer AP, Sondel PM, Sollinger HW. Improved renal allograft survival following donor-specific transfusions. III. Kinetics of mixed lymphocyte culture responses before and after transplantation. Transplantation. 45:1988;127-132.
20. Goulmy E, Stijnen T, Groenewoud AF, et al. Renal transplant patients monitored by the cell-mediated lympholysis assay: evaluation of its clinical value. Transplantation. 48:1989;559-563.
21. Van der Mast BJ, Hornstra N, Ruigrok MB, Claas FH, van Rood JJ, Lagaaij EL. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism. Lancet. 343:1994;753-757.
22. Bijleveld CGE, Klompmaker IJ, Van den Berg AP, et al. Incidence, risk factors and outcome of antithymocyte globulin treatment of steroid-resistant rejection after liver transplantation. Transplant Int. 9:1996;570-575.
23. Van Twuyver E, de Hoop J, ten Berge IJ, et al. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. Transplantation. 61:1996;1392-1397.
24. Schlitt HJ, Raddatz G, Steinhoff G, Wonigeit K, Pichlmayr R. Passenger lymphocytes in human liver allografts and their potential role after transplantation. Transplantation. 56:1993;951-955.
25. Starzl TE, Demetris AJ, Murase N, Thomson AW, Trucco M, Ricordi C. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. [Review] ImmunoL Today. 14:1993;326-332.
26. Davies HS, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation. 47:1989;524-527.
27. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. Human Immunol. 40:1994;191-201.
28. Calne Ry, Sells RA, Pena JR. Induction of immunologic tolerance by procine liver allografts. Nature. 223:1969;472-476.
29. Calne RY, Davies HS. Organ graft tolerance: the liver effect. Lancet. 343:1994;67-68.
30. Kobayashi E, Kamada N, Enosawa S, Toyama N, Walker NI, Miyata M. Prevention by liver transplantation of the graft-versus-host reaction and allograft rejection in a rat model of small bowel transplantation. Transplantation. 57:1994;177-181.
31. Caillat-Zucman S, Legendre C, Suberbielle C, et al. Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Human Immunol. 41:1994;91-95.
32. Schlitt HJ, Hundrieser J, Ringe B, Pichlmayr R. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. [Letter] N Engl J Med. 330:1994;646-647.
33. Suberbielle C, Caillat-Zucman S, Legendre C, et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet. 343:1994;1468-1469.
34. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 19:1994;916-924.
35. Hamano K, Rawsthorne M, Bushell A, Morris PJ, Wood KJ. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts. Transplant Proc. 27:1995;151-152.
36. Martin DR, Miller RG. In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med. 170:1989;679-690.
37. Hiruma K, Nakamura H, Henkart PA, Gress RE. Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes. J Exp Med. 175:1992;863-868.
38. Jamieson NV, Joysey V, Friend PJ, et al. Graft-versus-host disease in solid organ transplantation. Transplant Int. 4:1991;67-71.
39. Kosmatopoulos K, Scott-Algara D, Orbach-Arbouys S, Halle-Pannenko O. Specific resistance to local graft-verus-host reaction in F1 hybrids pretreated intravenously with parent-strain spleen cells. Role of cytotoxic T lymphocytes directed against receptors for the major histocompatibility complex. Transplantation. 46:1988;570-574.
40. Lehmann PV, Drexler K, Tary-Lehmann M, et al. Graft-versus-host resistance induced by class II major histocompatibility complex-specific T cell clones. J Exp Med. 173:1991;333-341.
41. Pirenne J, Williams JG, Mayoral JL, Nakhleh RE, Dunn DL. Resistance to graft-versus-host disease following small bowel transplantation. Transplantation. 51:1991;51-57.
42. Klompmaker JJ, Gouw ASH, Haagsma EB, Verwer R, Slooff MJH. Histological and biochemical effects of cyclosporine-A withdrawal from a triple drug regimen after over two years of treatment in liver transplant patients. J Hepatol. 22:1995;151-157.
43. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immuno-suppression in liver transplant recipients. Transplantation. 63:1997;243-249.